ClinicalTrials.gg
Not yet recruitingNCT07237789Updated Aug 28, 2026

Impact of Core Stability Training on Pain and Function in Patient With Shoulder Impingement Syndrome Among Manual Operated Hand Workers

An interventional study of Experimental and Control in Shoulder Impingement Syndrome, sponsored by Cairo University. Not yet recruiting. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 30 studies in Shoulder Impingement Syndrome by Cairo University — 14 open to participants now, 16 under way, none of them phase 3. Shoulder Impingement Syndrome · Cairo University.

Planned enrollment
20th of 26
40 · median 49
Started
2026
with 5 others
No phase
26 of 30
11 open now
Primary completion
2026-09
later than 10 of 15 live
Registered
22nd of 30
by date

Among the 30 studies in Shoulder Impingement Syndrome by Cairo University, this one is the 20th largest by planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2026, is one of 26 with no phase, reaches primary completion later than 10 of the 15 other live ones, and was the 22nd registered.

Shoulder Impingement Syndrome

320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

14 of the 30 studies in Shoulder Impingement Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 25 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Shoulder Impingement Syndrome by Cairo University, or all of them as a file.
02

Study summary

Even at the early stage of employment exposure to mechanical factors such as lifting heavy weights, working with hands at or above shoulder level, and pushing or pulling heavy loads are independent risk factors for new-onset shoulder pain . Shoulder-related problems among workers doing spading are 53.1% and 57.7% among workers brick carrying tasks, these shoulder issues may be the result of repetitive awkward movement (beyond ninety degree raising with abduction position) of the shoulder during these activities .

Read the detailed description

The highest prevalence of shoulder impingement syndrome is among slaughterhouses as they are exposed to a combination of repetitive shoulder movements and sustained elevated arm .

Several of workplace physical exposures are implicated in the causation and/or increasing shoulder disorders. Occupational exposures including manual handling heavy lifting, pushing, pulling, holding, carrying), working above shoulder height, and repetitive work are the most frequent causes of shoulder disorders specifically the subacromial impingement syndrome.

Shoulder-related problems among workers doing spading are 53.1% and 57.7% among workers brick carrying tasks, these shoulder issues may be the result of repetitive awkward movement (beyond ninety degree raising with abduction position) of the shoulder during these activities.

03

Conditions studied

  • Shoulder Impingement Syndrome

Keywords

  • Core Stability
  • Function
  • Hand Worker
  • Shoulder Impingement
04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

manually operated hand workers (males and females), Age from 25-to

-40 years, Shoulder impingement syndrome, and with No previous history of shoulder surgery that may affect their performance.

Exclusion criteria

Exclusion Criteria:

Patient who has a history of shoulder instability, History of shoulder dislocation, Patient who has current symptoms related to the cervical spine, Patient who has a history of acromioclavicular pain, and Low back pain (LBP) will be excluded.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Control

    Control group will receive traditional physiotherapy

    Other: Control

  • Experimental
    Experimental

    Other: Experimental

Interventions

  • OtherExperimental

    Core stability training will be used for experimental group

  • OtherControl

    Traditional physiotherapy

06

What researchers measure

Primary outcomes

  1. Pain intensity level

    Numerical Pain Rating Scale will be used to assess shoulder pain intensity level with zero indicates there is no pain and ten indicates the pain is severe intolerable

    Time frame: 8 weeks

Secondary outcomes

  1. Function

    DASH-Arabic a self-administered outcome measure will be used to assess disability in patients

    Time frame: 8 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Sep 2026, 1 month later.

Of 170 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 1 month is below that.

Counting every sponsor, half of 172 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2025
First posted
Nov 20, 2025
StartEst.
Aug 2026
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07237789
Lead sponsor
Cairo University
Responsible party
Salah Eid Ahmed Ali (Assistant Lecturer, Cairo University) — Principal investigator
First posted
Nov 20, 2025
Start date
Aug 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Aug 28, 2026

Study contacts

Salah Eid Ahmed Ali
Contact
Salah.Eid@Sue.edu.eg
+01158125773

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion